Page 199 - EJMO-9-1

Eurasian Journal of Medicine and
Oncology
Research on hypoxia and ECM in cancer

stimulated coactivator for hypoxia-inducible factor 1. Cell. negative breast cancer. Mater Today. 2024;76:9-27.
2011;145(5):732-744.
95. Sada M, Ohuchida K, Horioka K, et al. Hypoxic stellate cells
doi: 10.1016/j.cell.2011.03.054 of pancreatic cancer stroma regulate extracellular matrix
fiber organization and cancer cell motility. Cancer Lett.
84. Ceylan-Isik AF, Guo KK, Carlson EC, et al. Metallothionein 2016;372(2):210-218.
abrogates GTP cyclohydrolase I inhibition-induced cardiac
contractile and morphological defects: Role of mitochondrial doi: 10.1016/j.canlet.2016.01.016
biogenesis. Hypertension. 2009;53(6):1023-1031. 96. Topalovski M, Hagopian M, Wang M, Brekken RA.
doi: 10.1161/HYPERTENSIONAHA.108.123422 Hypoxia and transforming growth factor β cooperate to
induce fibulin-5 expression in pancreatic Cancer This
85. Gentric G, Mieulet V, Mechta-Grigoriou F. Heterogeneity in
cancer metabolism: New concepts in an old field. Antioxid work was supported in part by American Cancer Society
Grant RSG-10-244-01-CSM (to R. A. B.), the Joe and
Redox Signal. 2017;26(9):462-485.
Jessie Crump Medical Research Foundation (to R. A. B.),
doi: 10.1089/ars.2016.6750 National Institutes of Health Grants R01 CA118240 (to R.
A. B.) and T32 GM008203 (to M. T.), and the Effie Marie
86. Schmidt MW, Connolly JA, Günther D, Bogaerts M. Element
partitioning: The role of melt structure and composition. Cain Scholarship in Angiogenesis Research (to R. A. B.).
Science. 2006;312(5780):1646-1650. R. A. B. is a co-founder of Tuevol Therapeutics, a company
that is developing therapeutics that target the tumor
doi: 10.1126/science.1126690 microenvironment. The content is solely the responsibility
of the authors and does not necessarily represent the official
87. Won KY, Lim SJ, Kim GY, et al. Regulatory role of p53 in
cancer metabolism via SCO2 and TIGAR in human breast views of the National Institutes of Health. J Biol Chem.
cancer. Hum Pathol. 2012;43(2):221-228. 2016;291(42):22244-22252.
97. Li Z, Mo F, Guo K, et al. Nanodrug-bacteria conjugates-
doi: 10.1016/j.humpath.2011.04.021
mediated oncogenic collagen depletion enhances immune
88. Gilkes DM, Bajpai S, Wong CC, et al. Retraction: Procollagen checkpoint blockade therapy against pancreatic cancer.
lysyl hydroxylase 2 is essential for hypoxia-induced breast Med. 2024;5(4):348-367.e347.
cancer metastasis. Mol Cancer Res. 2023;21(10):1120.
doi: 10.1016/j.medj.2024.02.012
doi: 10.1158/1541-7786.MCR-12-0629
98. Ando A, Hashimoto N, Sakamoto K, et al. Repressive
89. Ju JA, Godet I, Ye IC, et al. Hypoxia selectively enhances role of stabilized hypoxia inducible factor 1α expression
integrin α5β1 receptor expression in breast cancer to on transforming growth factor β-induced extracellular
promote metastasis. Mol Cancer Res. 2017;15(6):723-734. matrix production in lung cancer cells. Cancer Sci.
doi: 10.1158/1541-7786.MCR-16-0338 2019;110(6):1959-1973.
90. Lu P, Weaver VM, Werb Z. The extracellular matrix: doi: 10.1111/cas.14027
A dynamic niche in cancer progression. J Cell Biol. 99. Sarma K, Akther MH, Ahmad I, et al. Adjuvant novel
2012;196(4):395-406. nanocarrier-based targeted therapy for lung cancer.
Molecules. 2024;29(5):1076.
doi: 10.1083/jcb.201102147
doi: 10.3390/molecules29051076
91. Dekker Y, Le Dévédec SE, Danen EHJ, Liu Q. Crosstalk
between hypoxia and extracellular matrix in the tumor 100. Mao XG, Xue XY, Lv R, et al. CEBPD is a master
microenvironment in breast cancer. Genes. 2022;13(9):1585. transcriptional factor for hypoxia regulated proteins in
glioblastoma and augments hypoxia induced invasion
doi: 10.3390/genes13091585
through extracellular matrix-integrin mediated EGFR/PI3K
92. Jing X, Yang F, Shao C, et al. Role of hypoxia in cancer pathway. Cell Death Dis. 2023;14(4):269.
therapy by regulating the tumor microenvironment. Mol doi: 10.1038/s41419-023-05788-y
Cancer. 2019;18(1):157.
101. Miroshnikova YA, Mouw JK, Barnes JM, et al. Tissue
doi: 10.1186/s12943-019-1089-9
mechanics promote IDH1-dependent HIF1α-tenascin C
93. Pola C, Formenti SC, Schneider RJ. Vitronectin-αvβ3 feedback to regulate glioblastoma aggression. Nat Cell Biol.
integrin engagement directs hypoxia-resistant mTOR 2016;18(12):1336-1345.
activity and sustained protein synthesis linked to invasion
by breast cancer cells. Cancer Res. 2013;73(14):4571-4578. doi: 10.1038/ncb3429
102. Tse APW, Sze KMF, Shea QTK, et al. Hepatitis transactivator
doi: 10.1158/0008-5472.CAN-13-0218
protein X promotes extracellular matrix modification
94. Lv F, Lian Y, Tao L, et al. Self-reinforcing nano-spearhead through HIF/LOX pathway in liver cancer. Oncogenesis.
drives the efficacy of CAR-T cells against progressive triple 2018;7(5):44.

Volume 9 Issue 1 (2025) 191 doi: 10.36922/ejmo.7116